Data from the Nexvax2 study shows celiac patients exposed to gluten react within two hours and experience nausea and vomiting, not the classic lower digestive symptoms commonly associated with celiac disease.
Continue ReadingEven in the midst of the COVID-19 pandemic, celiac disease patients need treatments and a cure. On March 8, the Celiac Disease Foundation sponsored the First SSCD Consensus Workshop: Research Opportunities in Celiac Disease 2020 to inform NIH funding needs.
Continue ReadingWe are well on the way to assembling a grassroots advocacy team that can help make celiac disease a national priority in communities across the country
Continue ReadingA recent review found that overall, the incidence of celiac disease has been rising since the second half of the 20th century into the 21st century in nearly every country where data on the disease are available.
Continue ReadingThe Celiac Disease Foundation National Patient Advocacy Summit in Washington, DC will train participants to advocate on celiac disease public policy priorities to Members of Congress.
Continue Reading
